Gene · 3205
Papers4,255
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 4,255
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Mechanisms of Cutaneous Squamous Cell Carcinoma. | Int J Mol Sci | 2022 | 35408839 | PubTator, text mining | PubMed |
| Liquid-Liquid Phase Separation in Cancer Signaling, Metabolism and Anticancer Therapy. | Cancers (Basel) | 2022 | 35406602 | PubTator, text mining | PubMed |
| Prognostic Impact of Circulating Methylated Homeobox A9 DNA in Patients Undergoing Treatment for Recurrent Ovarian Cancer. | Cancers (Basel) | 2022 | 35406538 | PubTator, text mining | PubMed |
| One genome, many cell states: epigenetic control of innate immunity. | Curr Opin Immunol | 2022 | 35405493 | PubTator, text mining | PubMed |
| UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment. | Leukemia | 2022 | 35397658 | PubTator, text mining | PubMed |
| Targeting matrix metallopeptidase 2 by hydroxyurea selectively kills acute myeloid mixed-lineage leukemia. | Cell Death Discov | 2022 | 35396375 | PubTator, text mining | PubMed |
| A proteolysis-targeting chimera molecule selectively degrades ENL and inhibits malignant gene expression and tumor growth. | J Hematol Oncol | 2022 | 35395864 | PubTator, text mining | PubMed |
| Phosphorylated MED1 links transcription recycling and cancer growth. | Nucleic Acids Res | 2022 | 35394046 | PubTator, text mining | PubMed |
| Saliva Based Liquid Biopsies in Head and Neck Cancer: How Far Are We From the Clinic? | Front Oncol | 2022 | 35387114 | PubTator, text mining | PubMed |
| Immune competence and spleen size scale with colony status in the naked mole-rat. | Open Biol | 2022 | 35382566 | PubTator, text mining | PubMed |
| [A three-series case report and literature review of acute myeloid leukemia with t(7;11)(p15;p15)/NUP98-HOXA9]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 35381677 | PubTator, text mining | PubMed |
| Comprehensive Landscape of HOXA2, HOXA9, and HOXA10 as Potential Biomarkers for Predicting Progression and Prognosis in Prostate Cancer. | J Immunol Res | 2022 | 35372588 | PubTator, text mining | PubMed |
| 5-Methylcytosine-Related Long Noncoding RNAs Are Potential Biomarkers to Predict Overall Survival and Regulate Tumor-Immune Environment in Patients with Bladder Cancer. | Dis Markers | 2022 | 35371346 | PubTator, text mining | PubMed |
| Expression Landscape and Functional Roles of HOXA4 and HOXA5 in Lung Adenocarcinoma. | Int J Med Sci | 2022 | 35370463 | PubTator, text mining | PubMed |
| The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL. | Cell Death Dis | 2022 | 35365636 | PubTator, text mining | PubMed |
| Targeting β-catenin in acute myeloid leukaemia: past, present, and future perspectives. | Biosci Rep | 2022 | 35352805 | PubTator, text mining | PubMed |
| SAHA Enhances Differentiation of CD34+CD45+ Hematopoietic Stem and Progenitor Cells from Pluripotent Stem Cells Concomitant with an Increase in Hemogenic Endothelium. | Stem Cells Transl Med | 2022 | 35349707 | PubTator, text mining | PubMed |
| Next-generation sequencing identifies HOXA6 as a novel oncogenic gene in low grade glioma. | Aging (Albany NY) | 2022 | 35349479 | PubTator, text mining | PubMed |
| The Diagnostic and Prognostic Values of HOXA Gene Family in Kidney Clear Cell Renal Cell Carcinoma. | J Oncol | 2022 | 35342423 | PubTator, text mining | PubMed |
| Targeting the histone H3 lysine 79 methyltransferase DOT1L in MLL-rearranged leukemias. | J Hematol Oncol | 2022 | 35331314 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3205/papers?page=46